First Manhattan’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.95M Buy
121,832
+4,828
+4% +$117K 0.01% 305
2026
Q1
$2.84M Buy
117,004
+25,635
+28% +$622K 0.01% 309
2025
Q4
$2.22M Buy
91,369
+27,419
+43% +$666K 0.01% 330
2025
Q3
$1.56M Buy
63,950
+725
+1% +$17.6K ﹤0.01% 366
2025
Q2
$1.53M Buy
63,225
+3,800
+6% +$91.7K ﹤0.01% 359
2025
Q1
$1.44M Buy
59,425
+24,260
+69% +$583K ﹤0.01% 341
2024
Q4
$843K Buy
35,165
+26,790
+320% +$645K ﹤0.01% 421
2024
Q3
$204K Buy
+8,375
New +$202K ﹤0.01% 652

Other funds holding IBDS

First Manhattan's IBDS Position: Q2 2026 in Review

First Manhattan increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 4.1% in Q2 2026, buying an estimated $117K and bringing the position to 121,832 shares worth $2.95M. The position accounts for 0.01% of the portfolio, ranked #305.

First Manhattan first reported a position in IBDS in Q3 2024 and has held it in 8 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • First Manhattan held 121,832 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $2.95M as of Q2 2026.
  • First Manhattan bought 4,828 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $117K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.01% of First Manhattan's portfolio in Q2 2026, its #305 holding.
  • First Manhattan first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2024 and has held it in 8 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on First Manhattan's 13F filing for Q2 2026, filed 14 Aug 2026.